×
ADVERTISEMENT

buparlisib

Buparlisib Improves PFS, But Toxicity Is Concerning

San Antonio—The combination of the PI3K inhibitor buparlisib and endocrine therapy with fulvestrant improved ...

JANUARY 26, 2017

SABCS 2016: Buparlisib Improves PFS in BELLE-3 Study, But Toxicity Is Concerning

San Antonio—The combination of PI3K inhibitor buparlisib and endocrine therapy with fulvestrant improved ...

DECEMBER 12, 2016

Load more